Three-Drug Regimens Make Case for a Role in Untreated and Relapsed/Refractory CLL

Published Date: 21 Jun 2024

Undetectable MRD rates of 90% or higher, PFS of 7 years or more

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

combating racial discrimination in next-generation breast cancer screening.

2.

Year in Review: Chronic Lymphocytic Leukemia

3.

An ancient signaling pathway and 20 years of research offer hope for rare cancer

4.

J. Craig Venter, Who Won the Race to Sequence the Human Genome, Dies at 79

5.

New imaging technique identifies glioblastoma patients who would benefit from immunotherapy


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot